Introduction {#Sec1}
============

The genus *Dendrobium* (Orchidaceae) contains approximately 1500 species globally, of which about 80 species grow in China \[[@CR1]\]. The stems of several plants in this genus are known as "Shi-Hu", which have been used for thousands of years as both traditional Chinese medicine and folk remedies for the treatment chronic atrophic gastritis, skin aging, fever, cardiovascular disease and a tonic for promoting the production of body fluid \[[@CR2]\]. Previous studies on this genus led to the isolation of a series of polysaccharides, phenolic compounds, alkaloids, and sesquiterpenoids \[[@CR1], [@CR3]--[@CR5]\], some of which possess various bioactivities including anti-inflammatory \[[@CR6]\], antimicrobial \[[@CR2]\], antioxidant \[[@CR7]\], antitumor \[[@CR8]\], antiplatelet aggregation \[[@CR9]\], immunomodulatory \[[@CR10]\], and against influenza A activities \[[@CR11]\].

*Dendrobium loddigesii*, a perennial epiphytic herb, is widely distributed in the southwestern area of China, such as Guangxi, Guizhou, and Yunnan Provinces \[[@CR12]\]. Its stem has been applied in folk medicine to treat gastrosis, fever, and dizziness \[[@CR13]\]. In continuing the search for structurally diverse and biologically active natural products from this genus \[[@CR1], [@CR5], [@CR14]--[@CR17]\], an in-depth investigation of pharmacologically active constituents from this plant species was performed herein. As a result, three new phenolic compounds (**1**--**3**) as well as eleven known ones (Fig. [1](#Fig1){ref-type="fig"}) were isolated from an 80% ethanolic extract of the stem of *D. loddigesii*. The isolation, structure elucidation, and biological evaluation of these compounds are presented herein.Fig. 1Chemical structures of compounds **1**--**14**

Results and Discussion {#Sec2}
======================

Compound **1**, obtained as white solid, gave a molecular formula of C~21~H~26~O~7~ as determined by the (−)-HRESIMS ion at *m/z* 389.1602 \[M−H\]^−^ (calcd for C~21~H~25~O~7~, 389.1606) with nine degrees of unsaturation. The ^1^H NMR spectrum of **1** contains seven aromatic protons at *δ*~H~ 6.85 (1H, d, *J* = 1.7 Hz), 6.75 (1H, d, *J* = 8.0 Hz), 6.68 (1H, dd, *J* = 8.0, 1.7 Hz), 7.01 (2H, d, *J* = 8.5 Hz) and 6.68 (2H, d, *J* = 8.5 Hz), suggesting the presence of a 1,3,4-trisubstituted benzene ring and a 1,4-disubstituted benzene ring. Its ^13^C NMR spectrum exhibited 21 carbon resonances including two methyl (one methoxy), four aliphatic methylene, nine methine (two *sp*^3^, seven *sp*^2^), and six quaternary carbons (one carbonyl, five olefinic including three oxygenated). The HMBC correlations (Fig. [2](#Fig2){ref-type="fig"}) of H-7/C-1 (*δ*~C~ 131.6), C-2 (*δ*~C~ 111.7), C-6 (*δ*~C~ 121.4), C-8 (*δ*~C~ 74.2) and C-10 (*δ*~C~ 65.3); H-9/C-7 (*δ*~C~ 83.8) and C-8 (*δ*~C~ 74.2); H-10/C-11 (*δ*~C~ 15.6); 3-OMe (*δ*~H~ 3.81)/C-3 (*δ*~C~ 149.1), together with correlations of H-7/H-8/H~2~-9 and H~2~-10/H~3~-11 from ^1^H--^1^H COSY spectrum (Fig. [2](#Fig2){ref-type="fig"}) indicated the presence of 7-*O*-ethylguaiacylglycerol \[[@CR18]\]. It has been reported that *J*~7,8~ was about 5 Hz for the erythro isomer and 7 Hz for the threo isomer in the cases of syringoyl-glycerols and guaiacylglycerol derivatives. Thus, compound **1** was considered to be the threo isomer with *J*~7,8~ (6.5 Hz) \[[@CR18]\]. The HMBC correlations of H-7ʹ (*δ*~H~ 2.79, t, *J* = 7.5 Hz)/C-8ʹ (*δ*~C~ 37.1), C-1ʹ (*δ*~C~ 132.7), C-2ʹ, 6ʹ (*δ*~C~ 130.2) and C-9ʹ (*δ*~C~ 174.6), H-8ʹ (*δ*~H~ 2.59, t, *J* = 7.5 Hz)/C-7ʹ (*δ*~C~ 31.0), C-1ʹ, and C-9ʹ, along with COSY cross-peaks of H-8ʹ/H-7ʹ indicated the presence of *p*-hydroxycoumaric acid \[[@CR19]\]. On the basis of the evidences described above, **1** was proposed to have a 7-*O*-ethylguaiacylglycerol moiety and a *p*-hydroxycoumaric acid via an ester linkage. The HMBC correlation from H-9 to C-9ʹ suggested the ester linkage was between C-9 and C-9ʹ. Thus, the structure of **1** was determined as shown.Fig. 2The key HMBC and COSY correlations of compounds **1**--**3**

(*R*)-4,5,4ʹ-Trihydroxy-3,3ʹ,α-trimethoxybibenzyl (**2**) was obtained as white solid. The HRESIMS spectrum of **2** displayed a quasimolecular ion peak at *m/z* 319.1180 \[M−H\]^−^ (calcd. for C~17~H~19~O~6~, 319.1187) with 8 degrees of unsaturation. The ^1^H NMR spectrum of **2** showed three methoxyl groups at *δ*~H~ 3.75 (3H, s), 3.70 (3H, s) and 3.17 (3H, s); one oxygenated methine proton at *δ*~H~ 4.13 (1H, t, *J* = 6.8 Hz, H-α); two methylene signals at *δ*~H~ 2.73 (1H, dd, *J* = 13.5, 6.9 Hz) and 2.96 (1H, dd, *J* = 13.5, 6.9 Hz); and five aromatic protons, appearing as a 1,3,4,5-tetrasubstituted aromatic ring at *δ*~H~ 6.28 (1H, d, *J* = 1.8 Hz) and 6.34 (1H, d, *J* = 1.8 Hz), and a 1,3,4-trisubstituted aromatic ring at *δ*~H~ 6.49 (1H, d, *J* = 2.0 Hz), 6.62 (1H, d, *J* = 8.0 Hz) and 6.52 (1H, dd, *J* = 8.0, 2.0 Hz). The ^13^CNMR and DEPT spectra of **2** showed three oxymethyls, one methylene, one oxygenated methine and 12 aromatic carbons (five oxygenated). Comparison of its NMR data (Table [1](#Tab1){ref-type="table"}) with those of dendrocandin C \[[@CR20]\] showed great similarities except for the presence of one more methoxyl group, which was located at C-3ʹ by the HMBC correlations from 3ʹ-OMe and H-5ʹ to C-3ʹ (*δ*~C~ 148.4). In addition, the multiple HMBC interactions (Fig. [2](#Fig2){ref-type="fig"}) of 3-OMe and H-2/C-3 (*δ*~C~ 149.5); α-OMe/C-α (*δ*~C~ 86.9) suggested the other methoxyl groups at C-3, and C-α, respectively. The absolute configuration at C-α was determined as *R* on the basis of the negative optical rotation ($\documentclass[12pt]{minimal}
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                \begin{document}$$\left[ \alpha \right]_{{\text{D}}}^{20}$$\end{document}$ --20.3, MeOH) \[[@CR15]\]. Accordingly, the structure of **2** was determined as shown.Table 1The ^1^H and ^13^C-NMR data of **1**--**3** (methanol-*d*~*4*~, *δ* in ppm, *J* in Hz)No.1^a^No.2^b^No.3^b^*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~*δ* ~H~*δ* ~C~1131.6 s1134.6 s126.85 d (1.7)111.7 d26.28 d (1.8)103.4 d25.29 dd (12.7, 3.1)80.4 d3149.1 s3149.5 s33.04 dd (17.1, 12.7)2.71 dd (17.1, 3.1)44.2 t4147.5 s4133.4 s4197.4 s56.75 d (8.0)116.0 d5146.5 s5165.4 s66.68 dd (8.0, 1.7)121.4 d66.34 d (1.8)108.6 d65.87 d (2.2)97.1 d74.14 d (6.5)83.8 d1ʹ131.1 s7168.483.82 m74.2 d2ʹ6.49 d (2.0)114.4 d85.91 d (2.2)96.2 d93.98 dd (11.5, 3.5)3.78 m66.5 t3ʹ148.4 s9164.6 s103.37, 3.32 m65.3 t4ʹ145.8 s10103.3 s111.14 t (7.0)15.6 q5ʹ6.62 d (8.0)115.7 d1ʹ136.3 s1ʹ132.7 s6ʹ6.52 dd (8.0, 2.0)123.1 d2ʹ6.62 d (2.0)129.9 d2ʹ7.01 d (8.5)130.2 dα4.13 t (6.9)86.9 d3ʹ154.7 s3ʹ6.68 d (8.5)116.2 dα*\'*2.73 dd (13.5, 6.9)2.96 dd (13.5, 6.9)45.1 t4ʹ137.7 s4ʹ156.8 s3ʹ-OMe3.70 s56.4 q5ʹ151.8 s5ʹ6.68 d (8.5)116.2 d3-OMe3.75 s56.5 q6ʹ6.61 d (2.0)108.2 d6ʹ7.01 d (8.5)130.2 dα-OMe3.17 s56.7 q3ʹ-OMe3.83 s56.4 q7ʹ2.79 t (7.5)31.0 t4ʹ-OMe3.77 s61.0 q8ʹ2.59 t (7.5)37.1 t9*\'*174.6 s3-OMe3.81 s56.3 q^a1^H and ^13^C NMR data were recorded at 500 MHz and 125 MHz, respectively^b1^H and ^13^C NMR data were recorded at 600 MHz and 150 MHz, respectively

(*S*)-5,7,5′-Trihydroxy-3′,4′-dimethoxyflavanone (**3**) was obtained as yellow amorphous powder and had the molecular C~17~H~16~O~7~ (10 indices of hydrogen deficiency) according to the (−)-HRESIMS ion at m/z 331.0819 \[M -- H\]^−^ (calcd 331.0823). The UV absorption maxima at 206 and 294 nm indicated the presence of a flavanone \[[@CR21]\]. The ^1^H NMR spectrum (Table [1](#Tab1){ref-type="table"}) showed three signals in non-aromatic region placed at *δ*~H~ 5.29 (1H, dd, *J* = 12.7, 3.1, H-2), 3.04 (1H, dd, *J* = 17.1, 12.7, H-3ax), and 2.71 (1H, dd, *J* = 17.1, 3.1, H-3 eq), four aromatic protons *δ*~H~ 5.87 (1H, d, *J* = 2.2, H-6), 5.91 (1H, d, *J* = 2.2, H-8), 6.62 (1H, d, *J* = 2.0, H-2ʹ) and 6.61 (1H, d, *J* = 2.0, H-6ʹ), two methoxyl groups *δ*~H~ 3.83 (3H, s) and 3.77 (3H, s). The ^13^C NMR and DEPT spectra (Table [1](#Tab1){ref-type="table"}) contain resonances for 17 carbons including one two methoxy, one methylene, one methine, one carbonyl carbon and 12 aromatic carbons. Comprehensive analysis of its NMR data indicated that its planar structure is closely related with that of dihydrotricin \[[@CR22]\], except for the OH-4ʹ and OCH~3~-5ʹ resonances in dihydrotricin were transposed in **3**. This was confirmed by the HMBC cross-peaks (Fig. [2](#Fig2){ref-type="fig"}) from H-2ʹ, H-6ʹ and OCH~3~-4ʹ to C-4ʹ (*δ*~C~ 137.7), from H-6ʹ to C-5ʹ (*δ*~C~ 151.8). The absolute configuration at C-2 was postulated as being in the *S*-form on the basis of a negative specific rotation value (-- 46.64, MeOH) in its optical rotation \[[@CR23]\]. Therefore, the structure of compound **3** was thus unambiguously assigned as shown.

Eleven known compounds were identified to be crepidatin **4** \[[@CR24]\], moscatilin **5** \[[@CR25]\], 4,5,4′-trihydroxy-3,3′-dimethoxybibenzyl **6** \[[@CR26]\], 4′,5-dihydroxy-3,3′-dimethoxybibenzyl **7** \[[@CR27]\], tristin **8** \[[@CR28]\], batatasin III **9** \[[@CR27]\], 3,5,3′-hydroxybibenzyl **10** \[[@CR29]\], aphyllals C **11** \[[@CR15]\], densiflorol A **12** \[[@CR30]\], dihydroconiferyl dihydro-*p*-coumarate **13** \[[@CR31]\], *p*-hydroxyphenethyl *trans*-ferulate **14** \[[@CR32]\] by spectroscopic analysis and comparing their spectral data with literature.

Phenolic compounds, are an essential part of the human diet and are known as powerful antioxidants due to their potent chain breaking action and they may contribute directly to the anti-oxidative activity \[[@CR33]\]. The DPPH radical scavenging assay is one of the most common and relatively quick methods used for evaluating antioxidant activity. Compounds that can donate a hydrogen atom to the DPPH radical, and then gives rise to the reduced form of DPPH which will be considered as potential antioxidant agents. All compounds were evaluated for their DPPH radical scavenging activities. The present results (Table [2](#Tab2){ref-type="table"}) exhibited that the majority of the phenolic compounds (**1**, **4**--**8**, **13** and **14**) showed significant activities with scavenging capacities ranging from 89.411 to 94.278% at 100 μg/mL.Table 2Antioxidant, tyrosinase inhibitory and collagen production activities of compounds **1**--**14**CompoundDPPH radical scavenging % (at 100 μg/mL)Tyrosinase inhibition % (at 100 μg/mL)Tyrosinase inhibition IC~50~ (μg/mL)Collagen production % (at 10 μg/mL)Collagen production EC~50~ μg/mL**1**91.43531.421NA− 13.987NA**2**35.276− 12.888NA− 3.515NA**3**13.3225.432NA22.974NA**4**89.4113.076NA22.974NA**5**92.9121.767NA12.747NA**6**93.68112.827NA33.062NA**7**93.39113.358NA29.157NA**8**90.2650.065NA24.552NA**9**26.644− 2.880NA78.9203.182**10**33.90375.36037.90416.665NA**11**29.29244.403152.5610.871NA**12**12.04115.249NA14.527NA**13**91.20423.822NA19.632NA**14**94.2782.618NA16.834NATrolox^a^96.089Kojic acid^b^57.3958.023TGF-β^c^66.290*NA* not active^a^Positive control used for DPPH radical scavenging assay at the concentration of 25 μg/mL^b^Positive control used for anti-tyrosinase assay at the concentration of 10 μg/mL^c^Positive control used for collagen production assay at the concentration of 0.01 μg/mL

On the other hand, tyrosinase is the copper containing enzyme and plays a critical role in controlling melanin biosynthesis pathway in melanocytes \[[@CR34]\]. Therefore, tyrosinase inhibitors became important constituents of cosmetics or as medicinal products for hyperpigmentation and developing skin whitening agents. In the present study, all the isolates were evaluated for their tyrosinase inhibitory activity (Table [2](#Tab2){ref-type="table"}). Kojic acid, a purported skin-lightening agent, was used as a positive control. 3,5,3′-hydroxybibenzyl (**10**) revealed a significant inhibitory activity with an IC~50~ value of 37.904 μg/mL. Aphyllals C (**11**) showed moderate inhibition (IC~50~, 152.56 μg/mL). All remaining compounds were inactive at concentrations up to 200 μg/mL. In this study, it can be concluded that compounds **10** and **11** can be potential candidate for the treatment of melanin biosynthesis related skin diseases.

Considering that this species medicinally used for skin aging, since, collagen is critical for skin strength and elasticity, and its degradation leads to wrinkles that accompany aging \[[@CR35]\]. Hence, all the compounds were also purposely evaluated for their effects on collagen production in HDFa. The results (Table [2](#Tab2){ref-type="table"}) showed that compound **9** significant stimulation HDFa collagen production activity (EC~50~ 3.182 μg/mL). Compounds **6** and **7** showed weaker activities, with collagen production of 33.062% and 29.157% at 10 μg/mL, respectively. The present results not only supported the ethnopharmacological usage of *D. loddigesii* but also provided a reliable structure template for developing collagen deficiency associated diseases such as burn and ulcer.

Experimental {#Sec3}
============

General Experimental Procedures {#Sec4}
-------------------------------

Optical rotation was obtained on a JASCO P-1020 digital polarimeter (Horiba, Tokyo, Japan). UV spectra were measured using a Shimadzu UV-2401 PC spectrophotometer (Shimadzu, Kyoto, Japan). IR spectra were obtained on a Bruker Tensor 27 infrared spectrophotometer (Bruker Optics GmbH, Ettlingen, Germany) with KBr pellets. Mass spectra were performed on an API QSTAR time-of-flight spectrometer (MDS Sciqaszex, Concord, Ontario, Canada) and LCMS-IT-TOF (Shimadzu, Kyoto, Japan) spectrometer. NMR spectra were recorded on DRX-500 and Av III-600 instruments with TMS as the internal standard (Bruker, Bremerhaven, Germany). The chemical shifts were given in *δ* (ppm) with reference to the solvent signal. Column chromatography was performed on silica gel (200--300 and 300--400 mesh, Qingdao Marine Chemical Inc., Qingdao, China), Lichroprep RP-18 gel (40--63 μm, Merck, Darmstadt, Germany), MCI gel CHP-20P (75--150 μm, Mitsubishi Chemical Corp., Tokyo, Japan), sephadex LH-20 (20--150 μm, Amersham Biosciences, Uppsala, Sweden), and YMC\*GEL ODS-A-HG (50 μm, YMC Co. Ltd. Japan). Fractions were monitored by TLC, and spots were visualized by UV light and sprayed with 10% H~2~SO~4~ in EtOH, followed by heating. 1,1-diphenyl-2-picrylhydrazyl (DPPH), Trolox, mushroom tyrosinase, L-Dopa, and Kojic acid were purchased from Sigma (USA); Transforming growth factor beta (TGF-β) was obtained from Peprotech (USA); Growth media DMEM (high glucose w/L-glut), Hank's balanced salt solution, fetal bovine serum were purchased from HyClone (USA); Procollagen peptide ELISA kit was obtained from TaKaRa (Japan). All other chemicals and solvents were of analytical grade.

Plant Material {#Sec5}
--------------

The stems of *D. loddigesii* were collected in September 2014 from Wenshan City, Yunnan Province, People\'s Republic of China and identified by Professor Hong Yu (Yunnan University, Kunming, People′s Republic of China). The voucher specimen (No. 20,140,829) has been deposited at the State key Laboratory of Phytochemistry and Plant Resource in West China, Kunming Institute of Botany, Chinese Academy of Sciences.

Extraction and Isolation {#Sec6}
------------------------

The dried and powdered stems (10.2 kg) of *D. loddigesii* were extracted three times with 80% ethanol under room temperature and concentrated under reduced pressure. Then, the residue was suspended in H~2~O and partitioned with EtOAc to obtain the EtOAc fraction (220 g), which was subjected to silica gel column chromatography eluted with a gradient of petroleum ether/acetone (15:1 to 0:1) to afford 22 fractions (Fr.1--22). Fr.11 (6 g) was subjected to silica gel CC eluted with CHCl~3~/MeOH (300:1), then followed by MCI column (MeOH/H~2~O gradient, 60:40--95:5) and silica gel CC (CHCl~3~/MeOH, 200:1) to yield **12** (4 mg). Fr.13 (850 mg) was separated over a column of MCI (MeOH/H~2~O, 60:40 to 95:5) to give five fractions (Fr.13.1--Fr.13.5). Fr.13.4 (150 mg) afforded compounds **4** (3 mg) and **5** (5 mg) by HPLC preparation (MeOH/H~2~O, 60:40). Fr.16 (19 g) was chromatographed on silica gel column eluted with CHCl~3~/MeOH (100:1 to 20:1) to afford 6 subfractions (Fr.16.1--Fr.16.6). Fr.16.4 (2.3 g) was applied MCI column eluted with MeOH/H~2~O (50:50--100:0) and then further fractionated over a column of sephadex LH-20 (MeOH/H~2~O, 90:10) to yield **7** (716 mg) and **13** (39 mg). By using the same conditions of Fr.16.4, Fr.16.6 (240 mg) afforded compound **9** (7 mg). Fr.18 (10 g) was separated by silica gel CC (CHCl~3~/MeOH, 100:1--20:1), then passed through MCI (MeOH/H~2~O gradient, 50:50--100:0) and sephadex LH-20 (MeOH/H~2~O, 90:10) columns to yield **3** (25 mg) and **11** (4 mg). Fr.19 (20 g) was subjected to MCI column eluted with MeOH/H~2~O (30:70--100:0) to obtain seven fractions (Fr.19.1--Fr.19.7). Fr.19.5 (2.3 g) was separated by repeated silica gel column (CHCl~3~/MeOH, 30:1) to afford **8** (15 mg) and **10** (7 mg). Fr.19.6 (4.3 g) was fractionated on a column of silica gel (CHCl~3~/MeOH, 30:1) to give 5 fractions (Fr.19.6.1-- Fr.19.6.5). Fr.19.6.1 (1.2 g) was subjected to silica gel column (CHCl~3~/MeOH, 30:1) and after purification by HPLC (MeOH/H~2~O, 45:55), providing **1** (15 mg). Fr.19.6.3 (540 mg) was applied to a column of sephadex LH-20 column eluted with MeOH/H~2~O (90:10), and then further purified by semipreparative HPLC (MeOH/H~2~O, 45:55) to furnish **2** (6 mg) and **6** (5 mg). Fr.20 (12 g) was applied to a MCI gel (MeOH/H~2~O, 30:70--100:0) chromatographic step and then was subjected to silica gel CC (CHCl~3~/MeOH, 30:1) to give **14** (21 mg).

*threo-*7-*O-*Ethyl*-*9-*O-*(4-hydroxyphenyl)propionyl-guaiacylglycerol (**1**): white solid; \[*α*\]~D~^26^ -- 3.72 (*c* 0.51, MeOH); UV (MeOH) λ~max~ (log *ε*) 203 (4.53), 225 (4.17), 280 (3.66) nm; IR (KBr) *ν*~max~ 3426, 1727, 1516, 829 cm^−1^; ^1^H and ^13^C NMR (CD~3~OD), see Table [1](#Tab1){ref-type="table"}; ESIMS *m/z* 389 \[M−H\]^−^, HRESIMS *m/z* 389.1602 \[M−H\]^−^ (calcd. for C~21~H~25~O~7~, 389.1606).

(*R*)-4,5,4′-Trihydroxy-3,3ʹ,α-trimethoxybibenzyl (**2**): white amorphous powder; \[*α*\]~D~^26^ --12.46 (*c* 1.07, MeOH); UV (MeOH) λ~max~ (log *ε*) 204 (4.59), 286 (3.75) nm; IR (KBr) *ν*~max~ 3418, 1607, 1517, 1455, 1434, 796 cm^−1^; ^1^H and ^13^C NMR (CD~3~OD), see Table [1](#Tab1){ref-type="table"}; ESIMS *m/z* 319 \[M−H\]^−^, HRESIMS *m/z* 319.1180 \[M−H\]^−^ (calcd. for C~17~H~19~O~6~, 319.1187).

(2*S*)-5,7,3ʹ-Trihydroxy-6,4,5-trimethoxyflavone (**3**): yellow amorphous powder; \[*α*\]~D~^26^ -- 46.64 (*c* 0.46, MeOH); UV (MeOH) λ~max~ (log *ε*) 206 (4.70), 294 (4.17) nm; IR (KBr) *ν*~max~ 3335, 2940, 1641, 1514, 1462, 1345, 1434, 1182, 1091, 998, 833 cm^−1^; ^1^H and ^13^C NMR (CD~3~OD), see Table [1](#Tab1){ref-type="table"}; ESIMS *m/z* 331 \[M−H\]^−^, HRESIMS *m/z* 331.0819 \[M−H\]^−^ (calcd. for C~17~H~15~O~7~, 331.0823).

DPPH Radical Scavenging Activity Assay {#Sec7}
--------------------------------------

The free radical scavenging activity assay was carried out according to previous method \[[@CR36]\] with some modifications. Briefly, 30 μL samples (1000 μg/mL, dissolved in ethanol) and Trolox (1 mM) were added to 270 μL DPPH solution (100 μM, dissolved in methanol), respectively. The reaction proceeded for 1 h at 37 °C on a 96-well microplate. The absorbance was then read at 515 nm and percentage of total radical scavenging activity was calculated using the following formula: inhibition % = \[(A~0~ − A~1~)/A~0~\] × 100%, where A~0~ is the absorbance of the DPPH without samples (control reaction) and A~1~ is the absorbance of DPPH incubated with the samples. All the tests were conducted in triplicate and Trolox was used as a positive control agent.

Mushroom Tyrosinase Inhibitory Assay {#Sec8}
------------------------------------

Tyrosinase activity inhibition was determined spectrophotometrically according to the method described previously \[[@CR36]\] with some modifications. Briefly, different concentrations of test compounds were prepared in 10% DMSO. Each of the sample solution (20 μM) were mixed with L-Dopa (1.25 mM), and diluted with 970 *μ*L of 0.05 mM sodium phosphate buffer (PBS, pH 6.8) in the test tubes. The reaction was initiated by adding mushroom tyrosinase (25 U/mL). The reaction mixture was incubated for 5 min at room temperature. The amount of Dopachrome in the mixture was determined by the measurement of the absorbance of each well at 490 nm. Kojic acid was used as positive control. The inhibitory percentage of tyrosinase was calculated according to the following equation: Percent inhibition = \[(A~0~ − A~1~)/A~0~\] × 100%, where A~0~ is the absorbance of the Dopachrome without test compounds (control reaction) and A~1~ is the absorbance of Dopachrome incubated with the test compounds.

Collagen Production by HDFa Assay {#Sec9}
---------------------------------

The HDFa cell line was obtained from Cascade Biologics. HDFa cells were seeded in 96-well plates containing DMEM with 10% FBS under a humidified atmosphere of 5% CO~2~ at 37 °C. After 24 h of incubation, the cells were treated with the test samples for 72 h (37 °C, 5% CO~2~). TGF-β was used as the positive control. Media (50 µL) was collected from each well, and froze at − 80 °C until it was assayed with procollagen peptide ELISA kit. The concentration of pro-collagen was obtained by measuring the absorbance at 450 nm on the microplate reader. Remove all media from cells and add 100 µL diluted MTS reagent to each well. The reaction incubated for 40 min at 37 °C. The absorbance was measured at 490 nm with a microplate reader. The increase percentage of collagen I production was calculated according to the following equation: cell viability (%) = (Mean OD~490~ sample/Mean OD~490~ control); increase of collagen production % = (A~1~/B/A~0~ − 1) × 100%. Where A~1~ is the absorbance with the samples, A~0~ is the absorbance without samples (control reaction), and B is cell viability.

Electronic supplementary material
=================================

 {#Sec10}

Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 18883 kb). Supplementary material (1H-, 13C NMR, DEPT, HSQC, HMBC, COSY, HRESIMS, IR, UV spectra of compounds 1--3) is available in the online version of this article and is accessible for authorized users.
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